,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,characteristics_ch1.7,characteristics_ch1.8,characteristics_ch1.9,characteristics_ch1.10,characteristics_ch1.11,characteristics_ch1.12,characteristics_ch1.13,characteristics_ch1.14,characteristics_ch1.15,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,data_processing,platform_id,contact_name,contact_email,contact_department,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,supplementary_file,supplementary_file.1,supplementary_file.2,supplementary_file.3,supplementary_file.4,supplementary_file.5,data_row_count
GSM269126,Patient 275 Core Set (cancer panel),GSM269126,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 5.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.24435318275154,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-275,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269126/GSM269126_1557290041_R008_C010_Red.xml.gz,502
GSM269127,Patient 276 Core Set (cancer panel),GSM269127,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 20.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to first rising PSA: 0.265571526351814,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 0.566735112936345,PSA Slope (ng/ml/yr): 0.332045454545454,Time (yrs) from PSA recurrence to systemic disease: 0.804928131416838,Years of Followup after RRP: 6.53798767967146,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-276,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269127/GSM269127_1557290041_R001_C011_Red.xml.gz,502
GSM269128,Patient 277 Core Set (cancer panel),GSM269128,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 52,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.6666666666667,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-277,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269128/GSM269128_1557290041_R002_C011_Red.xml.gz,502
GSM269129,Patient 278 Core Set (cancer panel),GSM269129,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 12.9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.36,Time (yrs) from RRP to first rising PSA: 2.5242984257358,Second Rising PSA (ng/ml): 0.55,Time (yrs) from RRP to second rising PSA: 3.53730321697467,PSA Slope (ng/ml/yr): 0.187560810810811,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.2833675564682,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-278,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269129/GSM269129_1557290041_R003_C011_Red.xml.gz,502
GSM269130,Patient 279 Core Set (cancer panel),GSM269130,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 36.1,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to first rising PSA: 4.93086926762491,Second Rising PSA (ng/ml): 3.5,Time (yrs) from RRP to second rising PSA: 6.21492128678987,PSA Slope (ng/ml/yr): 1.79120469083156,Time (yrs) from PSA recurrence to systemic disease: 2.98151950718686,Years of Followup after RRP: 10.2833675564682,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-279,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269130/GSM269130_1557290041_R004_C011_Red.xml.gz,502
GSM269131,Patient 280 Core Set (cancer panel),GSM269131,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 5.6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.2621492128679,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-280,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269131/GSM269131_1557290041_R005_C011_Red.xml.gz,502
GSM269132,Patient 281 Core Set (cancer panel),GSM269132,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 14.2,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.21081451060917,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 4.58590006844627,PSA Slope (ng/ml/yr): 0.266605839416058,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.85968514715948,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-281,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269132/GSM269132_1557290041_R006_C011_Red.xml.gz,502
GSM269133,Patient 282 Core Set (cancer panel),GSM269133,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 9.4,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 1.39082819986311,Second Rising PSA (ng/ml): 2.5,Time (yrs) from RRP to second rising PSA: 1.47296372347707,PSA Slope (ng/ml/yr): 24.35,Time (yrs) from PSA recurrence to systemic disease: 2.33812457221081,Years of Followup after RRP: 7.50444900752909,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-282,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269133/GSM269133_1557290041_R007_C011_Red.xml.gz,502
GSM269134,Patient 283 Core Set (cancer panel),GSM269134,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 75,PSA (ng/ml) at RRP: 34.7,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 1.1937029431896,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 1.38261464750171,PSA Slope (ng/ml/yr): 1.05869565217391,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.16495550992471,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-283,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269134/GSM269134_1557290041_R008_C011_Red.xml.gz,502
GSM269135,Patient 284 Core Set (cancer panel),GSM269135,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 8.7,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 2.98699520876112,Second Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to second rising PSA: 3.75359342915811,PSA Slope (ng/ml/yr): 0.782678571428572,Time (yrs) from PSA recurrence to systemic disease: 0.720054757015743,Years of Followup after RRP: 7.80561259411362,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-284,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269135/GSM269135_1557290041_R001_C012_Red.xml.gz,502
GSM269136,Patient 285 Core Set (cancer panel),GSM269136,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 36.1,Revised Gleason Score: 9,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.7713894592745,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-285,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269136/GSM269136_1557290041_R002_C012_Red.xml.gz,502
GSM269137,Patient 286 Core Set (cancer panel),GSM269137,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.0944558521561,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1286,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269137/GSM269137_1632413020_R003_C002_Red.xml.gz,502
GSM269138,Patient 287 Core Set (cancer panel),GSM269138,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 2.9,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.76317590691307,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 3.96988364134155,PSA Slope (ng/ml/yr): 0.0453163771712159,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.3388090349076,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-287,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269138/GSM269138_1557290041_R004_C012_Red.xml.gz,502
GSM269139,Patient 288 Core Set (cancer panel),GSM269139,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 61,PSA (ng/ml) at RRP: 40.7,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.72142368240931,Second Rising PSA (ng/ml): 7.9,Time (yrs) from RRP to second rising PSA: 3.67967145790554,PSA Slope (ng/ml/yr): 8.0355,Time (yrs) from PSA recurrence to systemic disease: 2.24777549623546,Years of Followup after RRP: 12.6269678302533,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-288,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269139/GSM269139_1557290041_R005_C012_Red.xml.gz,502
GSM269140,Patient 289 Core Set (cancer panel),GSM269140,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.1813826146475,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-289,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269140/GSM269140_1557290041_R006_C012_Red.xml.gz,502
GSM269141,Patient 290 Core Set (cancer panel),GSM269141,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 75,PSA (ng/ml) at RRP: 4.2,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.4305270362765,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-290,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269141/GSM269141_1557290041_R007_C012_Red.xml.gz,502
GSM269142,Patient 291 Core Set (cancer panel),GSM269142,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 1.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 3.19507186858316,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 4.6570841889117,PSA Slope (ng/ml/yr): 0.341994382022472,Time (yrs) from PSA recurrence to systemic disease: 1.61533196440794,Years of Followup after RRP: 9.73853524982888,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-291,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269142/GSM269142_1557290041_R008_C012_Red.xml.gz,502
GSM269143,Patient 292 Core Set (cancer panel),GSM269143,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 4.7,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 4.47091033538672,Second Rising PSA (ng/ml): 0.36,Time (yrs) from RRP to second rising PSA: 4.81314168377823,PSA Slope (ng/ml/yr): 0.40908,Time (yrs) from PSA recurrence to systemic disease: 5.49760438056126,Years of Followup after RRP: 10.3353867214237,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-292,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269143/GSM269143_1557302050_R007_C001_Red.xml.gz,502
GSM269144,Patient 293 Core Set (cancer panel),GSM269144,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 6.4,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 1.71937029431896,Second Rising PSA (ng/ml): 0.63,Time (yrs) from RRP to second rising PSA: 2.08898015058179,PSA Slope (ng/ml/yr): 0.351722222222222,Time (yrs) from PSA recurrence to systemic disease: 2.49965776865161,Years of Followup after RRP: 10.009582477755,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-293,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269144/GSM269144_1557302050_R008_C001_Red.xml.gz,502
GSM269145,Patient 294 Core Set (cancer panel),GSM269145,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 17.9,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.295687885010267,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 0.629705681040383,PSA Slope (ng/ml/yr): 0.299385245901639,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 6.20396988364134,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-294,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269145/GSM269145_1557302050_R001_C002_Red.xml.gz,502
GSM269146,Patient 295 Core Set (cancer panel),GSM269146,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 4.5,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.3162217659138,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-295,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269146/GSM269146_1557302050_R002_C002_Red.xml.gz,502
GSM269147,Patient 296 Core Set (cancer panel),GSM269147,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 11,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to first rising PSA: 0.249144421629021,Second Rising PSA (ng/ml): 2.2,Time (yrs) from RRP to second rising PSA: 0.509240246406571,PSA Slope (ng/ml/yr): 4.22921052631579,Time (yrs) from PSA recurrence to systemic disease: 0.58590006844627,Years of Followup after RRP: 16.1560574948665,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-296,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269147/GSM269147_1557302050_R003_C002_Red.xml.gz,502
GSM269148,Patient 297 Core Set (cancer panel),GSM269148,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 5.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.24,Time (yrs) from RRP to first rising PSA: 2.62012320328542,Second Rising PSA (ng/ml): 0.32,Time (yrs) from RRP to second rising PSA: 2.83915126625599,PSA Slope (ng/ml/yr): 0.36525,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.34976043805613,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-297,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269148/GSM269148_1557302050_R004_C002_Red.xml.gz,502
GSM269149,Patient 298 Core Set (cancer panel),GSM269149,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 58,PSA (ng/ml) at RRP: 7.1,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.1642710472279,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-298,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269149/GSM269149_1557302050_R005_C002_Red.xml.gz,502
GSM269150,Patient 299 Core Set (cancer panel),GSM269150,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 12.3,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.1492128678987,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 2.65023956194387,PSA Slope (ng/ml/yr): 0.598770491803279,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.4517453798768,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-299,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269150/GSM269150_1557302050_R006_C002_Red.xml.gz,502
GSM269151,Patient 300 Core Set (cancer panel),GSM269151,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 21.3,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.37,Time (yrs) from RRP to first rising PSA: 4.88432580424367,Second Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to second rising PSA: 5.90006844626968,PSA Slope (ng/ml/yr): 0.915586253369272,Time (yrs) from PSA recurrence to systemic disease: 1.05133470225873,Years of Followup after RRP: 7.93702943189596,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-300,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269151/GSM269151_1557302050_R007_C002_Red.xml.gz,502
GSM269152,Patient 302 Core Set (cancer panel),GSM269152,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 8.3,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 2.80355920602327,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 3.90965092402464,PSA Slope (ng/ml/yr): 0.0904084158415842,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.2142368240931,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-302,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269152/GSM269152_1557302050_R001_C003_Red.xml.gz,502
GSM269153,Patient 303 Core Set (cancer panel),GSM269153,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 25.3,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 2.4558521560575,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 2.80082135523614,PSA Slope (ng/ml/yr): 0.869642857142857,Time (yrs) from PSA recurrence to systemic disease: 1.56878850102669,Years of Followup after RRP: 5.782340862423,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-303,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269153/GSM269153_1557302050_R002_C003_Red.xml.gz,502
GSM269154,Patient 304 Core Set (cancer panel),GSM269154,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 6,Stage: T2N0,Ploidy: NA,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.92128678987,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-304,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269154/GSM269154_1557302050_R003_C003_Red.xml.gz,502
GSM269155,Patient 305 Core Set (cancer panel),GSM269155,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 8.6,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.9144421629021,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-305,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269155/GSM269155_1557302050_R004_C003_Red.xml.gz,502
GSM269156,Patient 306 Core Set (cancer panel),GSM269156,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 10.1,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: NA,First Rising PSA (ng/ml): 38.69,Time (yrs) from RRP to first rising PSA: 6.12183436002738,Second Rising PSA (ng/ml): 88.9,Time (yrs) from RRP to second rising PSA: 6.98425735797399,PSA Slope (ng/ml/yr): 58.2196904761905,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.1471594798083,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1306,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269156/GSM269156_1632413020_R001_C004_Red.xml.gz,502
GSM269157,Patient 308 Core Set (cancer panel),GSM269157,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 9.7,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 1.02,Time (yrs) from RRP to first rising PSA: 3.90143737166324,Second Rising PSA (ng/ml): 3.7,Time (yrs) from RRP to second rising PSA: 4.65434633812457,PSA Slope (ng/ml/yr): 3.55952727272727,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.7994524298426,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-308,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269157/GSM269157_1557302050_R007_C003_Red.xml.gz,502
GSM269158,Patient 310 Core Set (cancer panel),GSM269158,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 76,PSA (ng/ml) at RRP: 5,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.3353867214237,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-310,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269158/GSM269158_1557302050_R008_C003_Red.xml.gz,502
GSM269159,Patient 311 Core Set (cancer panel),GSM269159,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 52,PSA (ng/ml) at RRP: 19.1,Revised Gleason Score: 7,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.3189596167009,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-311,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269159/GSM269159_1557302050_R001_C004_Red.xml.gz,502
GSM269160,Patient 312 Core Set (cancer panel),GSM269160,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 6.5,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to first rising PSA: 0.191649555099247,Second Rising PSA (ng/ml): 1.9,Time (yrs) from RRP to second rising PSA: 0.251882272416153,PSA Slope (ng/ml/yr): 8.30113636363636,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 5.75770020533881,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-312,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269160/GSM269160_1557302050_R002_C004_Red.xml.gz,502
GSM269161,Patient 313 Core Set (cancer panel),GSM269161,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 7.4,Revised Gleason Score: 6,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.6331279945243,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-313,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269161/GSM269161_1557302050_R003_C004_Red.xml.gz,502
GSM269162,Patient 314 Core Set (cancer panel),GSM269162,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 10.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.83162217659138,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 3.04722792607803,PSA Slope (ng/ml/yr): 0.0822635135135135,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.4106776180698,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-314,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269162/GSM269162_1557302050_R004_C004_Red.xml.gz,502
GSM269163,Patient 315 Core Set (cancer panel),GSM269163,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 8.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.0616016427105,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-315,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269163/GSM269163_1557302050_R005_C004_Red.xml.gz,502
GSM269164,Patient 316 Core Set (cancer panel),GSM269164,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 13.3,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 4.25188227241615,Second Rising PSA (ng/ml): 1.8,Time (yrs) from RRP to second rising PSA: 5.30869267624914,PSA Slope (ng/ml/yr): 1.32474093264249,Time (yrs) from PSA recurrence to systemic disease: 1.30047912388775,Years of Followup after RRP: 9.96303901437372,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-316,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269164/GSM269164_1557302050_R006_C004_Red.xml.gz,502
GSM269165,Patient 317 Core Set (cancer panel),GSM269165,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 5.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.26,Time (yrs) from RRP to first rising PSA: 3.40041067761807,Second Rising PSA (ng/ml): 0.35,Time (yrs) from RRP to second rising PSA: 3.8466803559206,PSA Slope (ng/ml/yr): 0.201671779141104,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.93908281998631,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-317,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269165/GSM269165_1557302050_R007_C004_Red.xml.gz,502
GSM269166,Patient 318 Core Set (cancer panel),GSM269166,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 8.6,Revised Gleason Score: 7,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.23,Time (yrs) from RRP to first rising PSA: 2.8911704312115,Second Rising PSA (ng/ml): 0.46,Time (yrs) from RRP to second rising PSA: 3.89869952087611,PSA Slope (ng/ml/yr): 0.22828125,Time (yrs) from PSA recurrence to systemic disease: 3.92881587953457,Years of Followup after RRP: 9.00479123887748,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-318,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269166/GSM269166_1557302050_R008_C004_Red.xml.gz,502
GSM269167,Patient 319 Core Set (cancer panel),GSM269167,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 9.8,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 0.454483230663929,Second Rising PSA (ng/ml): 0.9,Time (yrs) from RRP to second rising PSA: 1.50855578370979,PSA Slope (ng/ml/yr): 0.379480519480519,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.1300479123888,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-319,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269167/GSM269167_1557302050_R001_C005_Red.xml.gz,502
GSM269168,Patient 320 Core Set (cancer panel),GSM269168,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 53,PSA (ng/ml) at RRP: 20.5,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.38,Time (yrs) from RRP to first rising PSA: 4.9555099247091,Second Rising PSA (ng/ml): 0.66,Time (yrs) from RRP to second rising PSA: 5.492128678987,PSA Slope (ng/ml/yr): 0.521785714285714,Time (yrs) from PSA recurrence to systemic disease: 3.83025325119781,Years of Followup after RRP: 10.5598904859685,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-320,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269168/GSM269168_1557302050_R002_C005_Red.xml.gz,502
GSM269169,Patient 321 Core Set (cancer panel),GSM269169,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 1.1,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.9911019849418,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-321,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269169/GSM269169_1557302050_R003_C005_Red.xml.gz,502
GSM269170,Patient 322 Core Set (cancer panel),GSM269170,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 56,PSA (ng/ml) at RRP: 2.8,Revised Gleason Score: 6,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.31074606433949,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 2.46132785763176,PSA Slope (ng/ml/yr): 1.32818181818182,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.76659822039699,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-322,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269170/GSM269170_1557302050_R004_C005_Red.xml.gz,502
GSM269171,Patient 323 Core Set (cancer panel),GSM269171,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 61,PSA (ng/ml) at RRP: 15,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 6.90212183436003,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 7.34565366187543,PSA Slope (ng/ml/yr): 0.225462962962963,Time (yrs) from PSA recurrence to systemic disease: 3.55920602327173,Years of Followup after RRP: 14.2724161533196,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-323,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269171/GSM269171_1557302050_R005_C005_Red.xml.gz,502
GSM269172,Patient 324 Core Set (cancer panel),GSM269172,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 10.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 6.24229979466119,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-324,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269172/GSM269172_1557302050_R006_C005_Red.xml.gz,502
GSM269173,Patient 325 Core Set (cancer panel),GSM269173,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 39.6,Revised Gleason Score: 9,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 5.5,Time (yrs) from RRP to first rising PSA: 4.75290896646133,Second Rising PSA (ng/ml): 9.8,Time (yrs) from RRP to second rising PSA: 5.12799452429843,PSA Slope (ng/ml/yr): 11.4640510948905,Time (yrs) from PSA recurrence to systemic disease: 1.8425735797399,Years of Followup after RRP: 7.38945927446954,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1325,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269173/GSM269173_1632413020_R002_C004_Red.xml.gz,502
GSM269174,Patient 326 Core Set (cancer panel),GSM269174,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 4.3,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.5373032169747,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-326,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269174/GSM269174_1557302050_R008_C005_Red.xml.gz,502
GSM269175,Patient 327 Core Set (cancer panel),GSM269175,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 6.6,Revised Gleason Score: 9,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 0.361396303901437,Second Rising PSA (ng/ml): 15.1,Time (yrs) from RRP to second rising PSA: 0.758384668035592,PSA Slope (ng/ml/yr): 37.0287931034483,Time (yrs) from PSA recurrence to systemic disease: 0.788501026694045,Years of Followup after RRP: 2.19028062970568,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-327,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269175/GSM269175_1557302050_R001_C006_Red.xml.gz,502
GSM269176,Patient 329 Core Set (cancer panel),GSM269176,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 7.1,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 1.8425735797399,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 2.14647501711157,PSA Slope (ng/ml/yr): 0.263243243243243,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.27446954140999,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-329,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269176/GSM269176_1557302050_R003_C006_Red.xml.gz,502
GSM269177,Patient 330 Core Set (cancer panel),GSM269177,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 3.1,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.32,Time (yrs) from RRP to first rising PSA: 2.69952087611225,Second Rising PSA (ng/ml): 0.54,Time (yrs) from RRP to second rising PSA: 3.20328542094456,PSA Slope (ng/ml/yr): 0.436711956521739,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.29774127310062,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-330,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269177/GSM269177_1557302050_R004_C006_Red.xml.gz,502
GSM269178,Patient 331 Core Set (cancer panel),GSM269178,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 10.6,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.44832306639288,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 2.73511293634497,PSA Slope (ng/ml/yr): 0.0777127659574468,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.7344284736482,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-331,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269178/GSM269178_1557302050_R005_C006_Red.xml.gz,502
GSM269179,Patient 332 Core Set (cancer panel),GSM269179,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 26.4,Revised Gleason Score: 7,Stage: TxN+,Ploidy: NA,First Rising PSA (ng/ml): 0.26,Time (yrs) from RRP to first rising PSA: 5.17180013689254,Second Rising PSA (ng/ml): 0.56,Time (yrs) from RRP to second rising PSA: 5.96030116358658,PSA Slope (ng/ml/yr): 0.38046875,Time (yrs) from PSA recurrence to systemic disease: 3.23613963039014,Years of Followup after RRP: 12.3668720054757,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-332,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269179/GSM269179_1557302050_R006_C006_Red.xml.gz,502
GSM269180,Patient 334 Core Set (cancer panel),GSM269180,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 1.6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.35,Time (yrs) from RRP to first rising PSA: 9.1088295687885,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 9.71937029431896,PSA Slope (ng/ml/yr): 0.245683856502242,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.1232032854209,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-334,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269180/GSM269180_1557302050_R008_C006_Red.xml.gz,502
GSM269181,Patient 335 Core Set (cancer panel),GSM269181,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 56,PSA (ng/ml) at RRP: 6.8,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.89596167008898,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-335,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269181/GSM269181_1557302050_R001_C007_Red.xml.gz,502
GSM269182,Patient 336 Core Set (cancer panel),GSM269182,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 3.2,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.1047227926078,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-336,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269182/GSM269182_1557302050_R002_C007_Red.xml.gz,502
GSM269183,Patient 337 Core Set (cancer panel),GSM269183,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 79,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: NA,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.862422997946612,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 1.57426420260096,PSA Slope (ng/ml/yr): 0.702403846153846,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 17.3004791238877,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-337,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269183/GSM269183_1557302050_R003_C007_Red.xml.gz,502
GSM269184,Patient 338 Core Set (cancer panel),GSM269184,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 9.5,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.323066392881588,Second Rising PSA (ng/ml): 2,Time (yrs) from RRP to second rising PSA: 0.610540725530459,PSA Slope (ng/ml/yr): 6.26142857142857,Time (yrs) from PSA recurrence to systemic disease: 0.339493497604381,Years of Followup after RRP: 7.87679671457906,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-338,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269184/GSM269184_1557302050_R004_C007_Red.xml.gz,502
GSM269185,Patient 339 Core Set (cancer panel),GSM269185,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 7,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to first rising PSA: 4.01642710472279,Second Rising PSA (ng/ml): 3.3,Time (yrs) from RRP to second rising PSA: 4.13963039014374,PSA Slope (ng/ml/yr): 15.4216666666667,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.280629705681,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-339,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269185/GSM269185_1557302050_R005_C007_Red.xml.gz,502
GSM269186,Patient 341 Core Set (cancer panel),GSM269186,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 19.4,Revised Gleason Score: 9,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.2922655715264,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-341,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269186/GSM269186_1557302050_R006_C007_Red.xml.gz,502
GSM269187,Patient 342 Core Set (cancer panel),GSM269187,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 3.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.8008213552361,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-342,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269187/GSM269187_1557302050_R007_C007_Red.xml.gz,502
GSM269188,Patient 343 Core Set (cancer panel),GSM269188,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 6.5,Revised Gleason Score: 6,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 4.41067761806982,Second Rising PSA (ng/ml): 0.9,Time (yrs) from RRP to second rising PSA: 6.40109514031485,PSA Slope (ng/ml/yr): 0.200962861072902,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.5420944558522,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-343,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269188/GSM269188_1557302050_R008_C007_Red.xml.gz,502
GSM269189,Patient 344 Core Set (cancer panel),GSM269189,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 14.3,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.3237508555784,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-344,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269189/GSM269189_1557302050_R001_C008_Red.xml.gz,502
GSM269190,Patient 345 Core Set (cancer panel),GSM269190,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 58,PSA (ng/ml) at RRP: 6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.13073237508556,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-345,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269190/GSM269190_1557302050_R002_C008_Red.xml.gz,502
GSM269191,Patient 346 Core Set (cancer panel),GSM269191,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 10.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.29226557152635,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 1.67282683093771,PSA Slope (ng/ml/yr): 0.262769784172662,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.5126625598905,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-346,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269191/GSM269191_1557302050_R003_C008_Red.xml.gz,502
GSM269192,Patient 347 Core Set (cancer panel),GSM269192,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 75,PSA (ng/ml) at RRP: 11.5,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to first rising PSA: 1.57152635181383,Second Rising PSA (ng/ml): 2.7,Time (yrs) from RRP to second rising PSA: 1.70020533880904,PSA Slope (ng/ml/yr): 10.8797872340426,Time (yrs) from PSA recurrence to systemic disease: 4.90622861054073,Years of Followup after RRP: 7.53456536618754,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-347,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269192/GSM269192_1557302050_R004_C008_Red.xml.gz,502
GSM269193,Patient 348 Core Set (cancer panel),GSM269193,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 7.2,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.232717316906229,Second Rising PSA (ng/ml): 0.8,Time (yrs) from RRP to second rising PSA: 0.632443531827515,PSA Slope (ng/ml/yr): 1.25085616438356,Time (yrs) from PSA recurrence to systemic disease: 3.33196440793977,Years of Followup after RRP: 9.42915811088296,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-348,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269193/GSM269193_1557302050_R005_C008_Red.xml.gz,502
GSM269194,Patient 349 Core Set (cancer panel),GSM269194,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 5.7,Revised Gleason Score: 6,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.1204654346338,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-349,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269194/GSM269194_1557302050_R006_C008_Red.xml.gz,502
GSM269195,Patient 350 Core Set (cancer panel),GSM269195,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 34,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.793976728268309,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 1.29500342231348,PSA Slope (ng/ml/yr): 0.798360655737705,Time (yrs) from PSA recurrence to systemic disease: 3.65503080082136,Years of Followup after RRP: 9.28952772073922,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-350,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269195/GSM269195_1557302050_R007_C008_Red.xml.gz,502
GSM269196,Patient 352 Core Set (cancer panel),GSM269196,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 10.4,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 17.138945927447,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-352,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269196/GSM269196_1557302050_R001_C009_Red.xml.gz,502
GSM269197,Patient 353 Core Set (cancer panel),GSM269197,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 11.4,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: NA,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 3.90143737166324,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 5.30047912388775,PSA Slope (ng/ml/yr): 0.0714774951076321,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.145106091718,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-353,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269197/GSM269197_1557302050_R002_C009_Red.xml.gz,502
GSM269198,Patient 354 Core Set (cancer panel),GSM269198,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 55,PSA (ng/ml) at RRP: 8,Revised Gleason Score: 9,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 4.33675564681725,Second Rising PSA (ng/ml): 0.85,Time (yrs) from RRP to second rising PSA: 4.65982203969884,PSA Slope (ng/ml/yr): 1.0833686440678,Time (yrs) from PSA recurrence to systemic disease: 2.81177275838467,Years of Followup after RRP: 8.87337440109514,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-354,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269198/GSM269198_1557302050_R003_C009_Red.xml.gz,502
GSM269199,Patient 355 Core Set (cancer panel),GSM269199,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 61,PSA (ng/ml) at RRP: 8.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.24435318275154,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-355,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269199/GSM269199_1557302050_R004_C009_Red.xml.gz,502
GSM269200,Patient 356 Core Set (cancer panel),GSM269200,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 13.3,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 2.1,Time (yrs) from RRP to first rising PSA: 0.342231348391513,Second Rising PSA (ng/ml): 3.2,Time (yrs) from RRP to second rising PSA: 0.629705681040383,PSA Slope (ng/ml/yr): 3.82642857142857,Time (yrs) from PSA recurrence to systemic disease: 0.766598220396988,Years of Followup after RRP: 15.4387405886379,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-356,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269200/GSM269200_1557302050_R005_C009_Red.xml.gz,502
GSM269201,Patient 357 Core Set (cancer panel),GSM269201,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 21.5,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.9780971937029,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-357,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269201/GSM269201_1557302050_R006_C009_Red.xml.gz,502
GSM269202,Patient 358 Core Set (cancer panel),GSM269202,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 6.4,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.922655715263518,Second Rising PSA (ng/ml): 7.6,Time (yrs) from RRP to second rising PSA: 0.966461327857632,PSA Slope (ng/ml/yr): 168.928125,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.90622861054073,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-358,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269202/GSM269202_1557302050_R007_C009_Red.xml.gz,502
GSM269203,Patient 359 Core Set (cancer panel),GSM269203,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 3.1,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 3.81930184804928,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 4.90349075975359,PSA Slope (ng/ml/yr): 0.0922348484848485,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.2655715263518,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1359,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269203/GSM269203_1632413020_R004_C004_Red.xml.gz,502
GSM269204,Patient 360 Core Set (cancer panel),GSM269204,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 54,PSA (ng/ml) at RRP: 4.8,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 5.41820670773443,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 5.51129363449692,PSA Slope (ng/ml/yr): 1.07426470588235,Time (yrs) from PSA recurrence to systemic disease: 1.95756331279945,Years of Followup after RRP: 8.8870636550308,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-360,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269204/GSM269204_1557302050_R001_C010_Red.xml.gz,502
GSM269205,Patient 361 Core Set (cancer panel),GSM269205,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 9.9,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.9650924024641,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-361,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269205/GSM269205_1557302050_R002_C010_Red.xml.gz,502
GSM269206,Patient 362 Core Set (cancer panel),GSM269206,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 67,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 3.75906913073237,Second Rising PSA (ng/ml): 2,Time (yrs) from RRP to second rising PSA: 5.25667351129363,PSA Slope (ng/ml/yr): 0.868053016453382,Time (yrs) from PSA recurrence to systemic disease: 3.41409993155373,Years of Followup after RRP: 13.7029431895962,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1362,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269206/GSM269206_1632413020_R007_C001_Red.xml.gz,502
GSM269207,Patient 363 Core Set (cancer panel),GSM269207,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 6.3,Revised Gleason Score: 6,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.71937029431896,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 1.84804928131417,PSA Slope (ng/ml/yr): 2.3313829787234,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.0396988364134,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-363,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269207/GSM269207_1557302050_R004_C010_Red.xml.gz,502
GSM269208,Patient 364 Core Set (cancer panel),GSM269208,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 8.3,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.8131416837782,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1364,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269208/GSM269208_1632413020_R005_C004_Red.xml.gz,502
GSM269209,Patient 365 Core Set (cancer panel),GSM269209,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 14.1,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 19.5,Time (yrs) from RRP to first rising PSA: 0.479123887748118,Second Rising PSA (ng/ml): 21.2,Time (yrs) from RRP to second rising PSA: 0.48186173853525,PSA Slope (ng/ml/yr): 620.925,Time (yrs) from PSA recurrence to systemic disease: 0.317590691307324,Years of Followup after RRP: 3.06639288158795,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-365,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269209/GSM269209_1557302050_R006_C010_Red.xml.gz,502
GSM269210,Patient 366 Core Set (cancer panel),GSM269210,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 54,PSA (ng/ml) at RRP: 7.9,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 2.17385352498289,Second Rising PSA (ng/ml): 0.8,Time (yrs) from RRP to second rising PSA: 3.17590691307324,PSA Slope (ng/ml/yr): 0.299385245901639,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.2251882272416,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-366,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269210/GSM269210_1557302050_R007_C010_Red.xml.gz,502
GSM269211,Patient 368 Core Set (cancer panel),GSM269211,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 15,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 0.750171115674196,Second Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to second rising PSA: 1.41820670773443,PSA Slope (ng/ml/yr): 1.04784836065574,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.61670088980151,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-368,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269211/GSM269211_1557302050_R001_C011_Red.xml.gz,502
GSM269212,Patient 369 Core Set (cancer panel),GSM269212,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 87.3,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.208076659822,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-369,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269212/GSM269212_1557302050_R003_C011_Red.xml.gz,502
GSM269213,Patient 370 Core Set (cancer panel),GSM269213,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 3.9,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.36002737850787,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 2.77618069815195,PSA Slope (ng/ml/yr): 0.240296052631579,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.170431211499,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-370,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269213/GSM269213_1557302050_R004_C011_Red.xml.gz,502
GSM269214,Patient 371 Core Set (cancer panel),GSM269214,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 27.8,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.6290212183436,Second Rising PSA (ng/ml): 1.5,Time (yrs) from RRP to second rising PSA: 2.37645448323066,PSA Slope (ng/ml/yr): 1.73928571428571,Time (yrs) from PSA recurrence to systemic disease: 0.731006160164271,Years of Followup after RRP: 5.42642026009583,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-371,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269214/GSM269214_1557302050_R005_C011_Red.xml.gz,502
GSM269215,Patient 372 Core Set (cancer panel),GSM269215,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: 5.5,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 2.35728952772074,Second Rising PSA (ng/ml): 3,Time (yrs) from RRP to second rising PSA: 5.68651608487337,PSA Slope (ng/ml/yr): 0.810999177631579,Time (yrs) from PSA recurrence to systemic disease: 2.50513347022587,Years of Followup after RRP: 9.5605749486653,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-372,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269215/GSM269215_1557302050_R006_C011_Red.xml.gz,502
GSM269216,Patient 373 Core Set (cancer panel),GSM269216,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 27.9,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 1.42368240930869,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 1.73032169746749,PSA Slope (ng/ml/yr): 0.326116071428572,Time (yrs) from PSA recurrence to systemic disease: 9.22108145106092,Years of Followup after RRP: 12.1122518822724,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-373,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269216/GSM269216_1557302050_R008_C011_Red.xml.gz,502
GSM269217,Patient 374 Core Set (cancer panel),GSM269217,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 2.4,Revised Gleason Score: 7,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 2.81724845995893,Second Rising PSA (ng/ml): 1,Time (yrs) from RRP to second rising PSA: 3.15947980835044,PSA Slope (ng/ml/yr): 1.1688,Time (yrs) from PSA recurrence to systemic disease: 0.577686516084873,Years of Followup after RRP: 5.93292265571526,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-374,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269217/GSM269217_1557302050_R002_C012_Red.xml.gz,502
GSM269218,Patient 375 Core Set (cancer panel),GSM269218,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: 15.7,Revised Gleason Score: 8,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 0.476386036960986,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 0.930869267624914,PSA Slope (ng/ml/yr): 0.660090361445783,Time (yrs) from PSA recurrence to systemic disease: 10.0862422997947,Years of Followup after RRP: 14.6091718001369,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-375,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269218/GSM269218_1557302050_R004_C012_Red.xml.gz,502
GSM269219,Patient 376 Core Set (cancer panel),GSM269219,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 9.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.13894592744695,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-376,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269219/GSM269219_1557302050_R005_C012_Red.xml.gz,502
GSM269220,Patient 378 Core Set (cancer panel),GSM269220,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 50,PSA (ng/ml) at RRP: 36,Revised Gleason Score: 9,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 1.30595482546201,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 1.31964407939767,PSA Slope (ng/ml/yr): 14.61,Time (yrs) from PSA recurrence to systemic disease: 1.00205338809035,Years of Followup after RRP: 4.01095140314853,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-378,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269220/GSM269220_1557302050_R007_C012_Red.xml.gz,502
GSM269221,Patient 379 Core Set (cancer panel),GSM269221,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: 2.1,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.3340177960301,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-379,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269221/GSM269221_1557311024_R008_C001_Red.xml.gz,502
GSM269222,Patient 380 Core Set (cancer panel),GSM269222,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 3.80561259411362,Second Rising PSA (ng/ml): 3.6,Time (yrs) from RRP to second rising PSA: 5.18001368925394,PSA Slope (ng/ml/yr): 2.32828685258964,Time (yrs) from PSA recurrence to systemic disease: 1.34976043805613,Years of Followup after RRP: 16.4490075290897,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-380,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269222/GSM269222_1557311024_R001_C002_Red.xml.gz,502
GSM269223,Patient 381 Core Set (cancer panel),GSM269223,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 75,PSA (ng/ml) at RRP: 7.4,Revised Gleason Score: 6,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.4715947980835,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1381,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269223/GSM269223_1632413020_R006_C004_Red.xml.gz,502
GSM269224,Patient 382 Core Set (cancer panel),GSM269224,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 8.7,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.69130732375086,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 3.2662559890486,PSA Slope (ng/ml/yr): 0.173928571428571,Time (yrs) from PSA recurrence to systemic disease: 2.75427789185489,Years of Followup after RRP: 13.7631759069131,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-382,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269224/GSM269224_1557311024_R003_C002_Red.xml.gz,502
GSM269225,Patient 383 Core Set (cancer panel),GSM269225,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 52,PSA (ng/ml) at RRP: 9.3,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 5.65639972621492,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 6.77070499657769,PSA Slope (ng/ml/yr): 0.0897420147420148,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.8658453114305,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-383,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269225/GSM269225_1557311024_R005_C002_Red.xml.gz,502
GSM269226,Patient 384 Core Set (cancer panel),GSM269226,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 51,PSA (ng/ml) at RRP: 11.9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 1.29,Time (yrs) from RRP to first rising PSA: 2.01505817932923,Second Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to second rising PSA: 2.5242984257358,PSA Slope (ng/ml/yr): 0.216008064516129,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.60164271047228,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-384,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269226/GSM269226_1557311024_R006_C002_Red.xml.gz,502
GSM269227,Patient 385 Core Set (cancer panel),GSM269227,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 6.7,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 4.44626967830253,Second Rising PSA (ng/ml): 3,Time (yrs) from RRP to second rising PSA: 5.48939082819986,PSA Slope (ng/ml/yr): 2.3007874015748,Time (yrs) from PSA recurrence to systemic disease: 2.01505817932923,Years of Followup after RRP: 10.6365503080082,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-385,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269227/GSM269227_1557311024_R007_C002_Red.xml.gz,502
GSM269228,Patient 386 Core Set (cancer panel),GSM269228,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 75,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.49691991786448,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 3.37303216974675,PSA Slope (ng/ml/yr): 0.342421875,Time (yrs) from PSA recurrence to systemic disease: 2.01505817932923,Years of Followup after RRP: 5.95482546201232,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-386,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269228/GSM269228_1557311024_R008_C002_Red.xml.gz,502
GSM269229,Patient 387 Core Set (cancer panel),GSM269229,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.2340862422998,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-387,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269229/GSM269229_1557311024_R001_C003_Red.xml.gz,502
GSM269230,Patient 388 Core Set (cancer panel),GSM269230,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 13.2,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.32717316906229,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 2.60369609856263,PSA Slope (ng/ml/yr): 1.44653465346535,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.337440109514,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-388,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269230/GSM269230_1557311024_R002_C003_Red.xml.gz,502
GSM269231,Patient 389 Core Set (cancer panel),GSM269231,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 16.8,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.7577002053388,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-389,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269231/GSM269231_1557311024_R003_C003_Red.xml.gz,502
GSM269232,Patient 390 Core Set (cancer panel),GSM269232,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: 24.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.632443531827515,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 0.884325804243669,PSA Slope (ng/ml/yr): 0.397010869565217,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.0239561943874,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-390,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269232/GSM269232_1557311024_R004_C003_Red.xml.gz,502
GSM269233,Patient 392 Core Set (cancer panel),GSM269233,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 4.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.82340862422998,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-392,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269233/GSM269233_1557311024_R006_C003_Red.xml.gz,502
GSM269234,Patient 393 Core Set (cancer panel),GSM269234,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 20.8,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 0.265571526351814,Second Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to second rising PSA: 0.361396303901437,PSA Slope (ng/ml/yr): 12.3141428571429,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 5.55783709787817,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-393,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269234/GSM269234_1557311024_R007_C003_Red.xml.gz,502
GSM269235,Patient 394 Core Set (cancer panel),GSM269235,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 61,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.9233401779603,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-394,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269235/GSM269235_1557311024_R008_C003_Red.xml.gz,502
GSM269236,Patient 395 Core Set (cancer panel),GSM269236,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 6.6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 6.35728952772074,Second Rising PSA (ng/ml): 2.6,Time (yrs) from RRP to second rising PSA: 6.85557837097878,PSA Slope (ng/ml/yr): 4.41510989010989,Time (yrs) from PSA recurrence to systemic disease: 4.92813141683778,Years of Followup after RRP: 13.5003422313484,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-395,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269236/GSM269236_1557311024_R001_C004_Red.xml.gz,502
GSM269237,Patient 396 Core Set (cancer panel),GSM269237,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 7.4,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.939082819986311,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 1.09787816563997,PSA Slope (ng/ml/yr): 1.88922413793103,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.9863107460643,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-396,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269237/GSM269237_1557311024_R002_C004_Red.xml.gz,502
GSM269238,Patient 397 Core Set (cancer panel),GSM269238,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 9.6,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.42778918548939,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-397,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269238/GSM269238_1557311024_R003_C004_Red.xml.gz,502
GSM269239,Patient 398 Core Set (cancer panel),GSM269239,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 7.5,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.76,Time (yrs) from RRP to first rising PSA: 7.66050650239562,Second Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to second rising PSA: 8.87337440109514,PSA Slope (ng/ml/yr): 0.445225733634312,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.8364134154689,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-398,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269239/GSM269239_1557311024_R004_C004_Red.xml.gz,502
GSM269240,Patient 399 Core Set (cancer panel),GSM269240,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: 5.6,Revised Gleason Score: 6,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.618754277891855,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 0.665297741273101,PSA Slope (ng/ml/yr): 2.14852941176471,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.9678302532512,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-399,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269240/GSM269240_1557311024_R005_C004_Red.xml.gz,502
GSM269241,Patient 400 Core Set (cancer panel),GSM269241,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 61,PSA (ng/ml) at RRP: 32.7,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.1245722108145,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-400,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269241/GSM269241_1557311024_R006_C004_Red.xml.gz,502
GSM269242,Patient 401 Core Set (cancer panel),GSM269242,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 23.7,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 0.878850102669405,Second Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to second rising PSA: 1.17453798767967,PSA Slope (ng/ml/yr): 2.70555555555556,Time (yrs) from PSA recurrence to systemic disease: 4.64887063655031,Years of Followup after RRP: 15.4496919917864,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-401,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269242/GSM269242_1557311024_R007_C004_Red.xml.gz,502
GSM269243,Patient 402 Core Set (cancer panel),GSM269243,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 2.5,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 1.31416837782341,Second Rising PSA (ng/ml): 0.55,Time (yrs) from RRP to second rising PSA: 1.56331279945243,PSA Slope (ng/ml/yr): 1.32453296703297,Time (yrs) from PSA recurrence to systemic disease: 2.58179329226557,Years of Followup after RRP: 4.78850102669405,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-402,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269243/GSM269243_1557311024_R008_C004_Red.xml.gz,502
GSM269244,Patient 403 Core Set (cancer panel),GSM269244,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 12.8,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 4.04380561259411,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 4.5968514715948,PSA Slope (ng/ml/yr): 0.180816831683168,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.1416837782341,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-403,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269244/GSM269244_1557311024_R001_C005_Red.xml.gz,502
GSM269245,Patient 404 Core Set (cancer panel),GSM269245,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 16.5,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.7310061601643,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-404,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269245/GSM269245_1557311024_R002_C005_Red.xml.gz,502
GSM269246,Patient 405 Core Set (cancer panel),GSM269246,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 55,PSA (ng/ml) at RRP: 6.8,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.8466803559206,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1405,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269246/GSM269246_1632413020_R007_C004_Red.xml.gz,502
GSM269247,Patient 406 Core Set (cancer panel),GSM269247,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.32785763175907,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 1.81793292265572,PSA Slope (ng/ml/yr): 0.408100558659218,Time (yrs) from PSA recurrence to systemic disease: 2.03422313483915,Years of Followup after RRP: 15.8740588637919,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-406,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269247/GSM269247_1557311024_R004_C005_Red.xml.gz,502
GSM269248,Patient 407 Core Set (cancer panel),GSM269248,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 1.9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 6.69952087611225,Second Rising PSA (ng/ml): 7.2,Time (yrs) from RRP to second rising PSA: 8.4517453798768,PSA Slope (ng/ml/yr): 3.766640625,Time (yrs) from PSA recurrence to systemic disease: 0.16974674880219,Years of Followup after RRP: 10.1409993155373,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-407,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269248/GSM269248_1557311024_R005_C005_Red.xml.gz,502
GSM269249,Patient 408 Core Set (cancer panel),GSM269249,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 5.2,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 2.89664613278576,Second Rising PSA (ng/ml): 1.5,Time (yrs) from RRP to second rising PSA: 4.53114305270363,PSA Slope (ng/ml/yr): 0.489447236180905,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.0698151950719,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-408,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269249/GSM269249_1557311024_R006_C005_Red.xml.gz,502
GSM269250,Patient 409 Core Set (cancer panel),GSM269250,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 20.8,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.9,Time (yrs) from RRP to first rising PSA: 0.996577686516085,Second Rising PSA (ng/ml): 4.2,Time (yrs) from RRP to second rising PSA: 1.59069130732375,PSA Slope (ng/ml/yr): 5.5544930875576,Time (yrs) from PSA recurrence to systemic disease: 3.85215605749487,Years of Followup after RRP: 11.1594798083504,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-409,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269250/GSM269250_1557311024_R007_C005_Red.xml.gz,502
GSM269251,Patient 410 Core Set (cancer panel),GSM269251,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 11.7,Revised Gleason Score: 6,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 0.569472963723477,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 0.974674880219028,PSA Slope (ng/ml/yr): 0.493581081081081,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.6297056810404,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-410,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269251/GSM269251_1557311024_R008_C005_Red.xml.gz,502
GSM269252,Patient 411 Core Set (cancer panel),GSM269252,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 17.3,Revised Gleason Score: 8,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.31211498973306,Second Rising PSA (ng/ml): 5.2,Time (yrs) from RRP to second rising PSA: 3.39493497604381,PSA Slope (ng/ml/yr): 1.62189165186501,Time (yrs) from PSA recurrence to systemic disease: 1.83709787816564,Years of Followup after RRP: 7.6933607118412,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-411,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269252/GSM269252_1557311024_R001_C006_Red.xml.gz,502
GSM269253,Patient 412 Core Set (cancer panel),GSM269253,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 14.9,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.09924709103354,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-412,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269253/GSM269253_1557311024_R002_C006_Red.xml.gz,502
GSM269254,Patient 413 Core Set (cancer panel),GSM269254,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 7,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.0766598220397,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-413,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269254/GSM269254_1557311024_R003_C006_Red.xml.gz,502
GSM269255,Patient 414 Core Set (cancer panel),GSM269255,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 5.1,Revised Gleason Score: 7,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.60506502395619,Second Rising PSA (ng/ml): 0.35,Time (yrs) from RRP to second rising PSA: 5.02669404517454,PSA Slope (ng/ml/yr): 0.355762987012987,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.06776180698152,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-414,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269255/GSM269255_1557311024_R004_C006_Red.xml.gz,502
GSM269256,Patient 415 Core Set (cancer panel),GSM269256,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 4.8,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.824093086926763,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 1.25941136208077,PSA Slope (ng/ml/yr): 0.229716981132075,Time (yrs) from PSA recurrence to systemic disease: 7.63039014373717,Years of Followup after RRP: 12.3832991101985,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-415,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269256/GSM269256_1557311024_R005_C006_Red.xml.gz,502
GSM269257,Patient 416 Core Set (cancer panel),GSM269257,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 10.4,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.6659822039699,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-416,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269257/GSM269257_1557311024_R006_C006_Red.xml.gz,502
GSM269258,Patient 417 Core Set (cancer panel),GSM269258,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 8.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 6.05338809034908,Second Rising PSA (ng/ml): 1.5,Time (yrs) from RRP to second rising PSA: 6.30527036276523,PSA Slope (ng/ml/yr): 3.17608695652174,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.27720739219713,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-417,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269258/GSM269258_1557311024_R007_C006_Red.xml.gz,502
GSM269259,Patient 418 Core Set (cancer panel),GSM269259,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 9,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.74,Time (yrs) from RRP to first rising PSA: 3.59479808350445,Second Rising PSA (ng/ml): 0.88,Time (yrs) from RRP to second rising PSA: 3.92881587953457,PSA Slope (ng/ml/yr): 0.419139344262295,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.6139630390144,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-418,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269259/GSM269259_1557311024_R008_C006_Red.xml.gz,502
GSM269260,Patient 419 Core Set (cancer panel),GSM269260,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 5.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.97809719370294,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-419,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269260/GSM269260_1557311024_R001_C007_Red.xml.gz,502
GSM269261,Patient 420 Core Set (cancer panel),GSM269261,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 57,PSA (ng/ml) at RRP: 14.3,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.974674880219028,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 1.37713894592745,PSA Slope (ng/ml/yr): 0.496938775510204,Time (yrs) from PSA recurrence to systemic disease: 1.79329226557153,Years of Followup after RRP: 4.16427104722793,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-420,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269261/GSM269261_1557311024_R002_C007_Red.xml.gz,502
GSM269262,Patient 421 Core Set (cancer panel),GSM269262,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 9.94113620807666,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 10.9158110882957,PSA Slope (ng/ml/yr): 0.102598314606742,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 17.6892539356605,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-421,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269262/GSM269262_1557311024_R003_C007_Red.xml.gz,502
GSM269263,Patient 422 Core Set (cancer panel),GSM269263,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 5.8,Revised Gleason Score: 6,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 3.39767282683094,Second Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to second rising PSA: 4.32580424366872,PSA Slope (ng/ml/yr): 0.646460176991151,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.4483230663929,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-422,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269263/GSM269263_1557311024_R004_C007_Red.xml.gz,502
GSM269264,Patient 423 Core Set (cancer panel),GSM269264,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 6.8,Revised Gleason Score: 5,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.5434633812457,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-423,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269264/GSM269264_1557311024_R005_C007_Red.xml.gz,502
GSM269265,Patient 424 Core Set (cancer panel),GSM269265,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.75906913073238,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-424,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269265/GSM269265_1557311024_R006_C007_Red.xml.gz,502
GSM269266,Patient 425 Core Set (cancer panel),GSM269266,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 24.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 6.5,Time (yrs) from RRP to first rising PSA: 0.246406570841889,Second Rising PSA (ng/ml): 7.5,Time (yrs) from RRP to second rising PSA: 0.473648186173854,PSA Slope (ng/ml/yr): 4.40060240963855,Time (yrs) from PSA recurrence to systemic disease: 2.16563997262149,Years of Followup after RRP: 3.00342231348392,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-425,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269266/GSM269266_1557311024_R007_C007_Red.xml.gz,502
GSM269267,Patient 426 Core Set (cancer panel),GSM269267,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 55,PSA (ng/ml) at RRP: 18.8,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.607802874743327,Second Rising PSA (ng/ml): 0.8,Time (yrs) from RRP to second rising PSA: 0.900752908966461,PSA Slope (ng/ml/yr): 1.70677570093458,Time (yrs) from PSA recurrence to systemic disease: 0.42984257357974,Years of Followup after RRP: 1.96851471594798,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-426,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269267/GSM269267_1557311024_R008_C007_Red.xml.gz,502
GSM269268,Patient 427 Core Set (cancer panel),GSM269268,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 5.3,Revised Gleason Score: 8,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.824093086926763,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 1.98220396988364,PSA Slope (ng/ml/yr): 0.172695035460993,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.0780287474333,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-427,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269268/GSM269268_1557311024_R001_C008_Red.xml.gz,502
GSM269269,Patient 429 Core Set (cancer panel),GSM269269,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 23.1,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.27,Time (yrs) from RRP to first rising PSA: 5.75222450376454,Second Rising PSA (ng/ml): 0.33,Time (yrs) from RRP to second rising PSA: 6.19028062970568,PSA Slope (ng/ml/yr): 0.13696875,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.2936344969199,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-429,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269269/GSM269269_1557311024_R003_C008_Red.xml.gz,502
GSM269270,Patient 430 Core Set (cancer panel),GSM269270,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 3.9,Revised Gleason Score: 6,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 17.2402464065708,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-430,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269270/GSM269270_1557311024_R004_C008_Red.xml.gz,502
GSM269271,Patient 432 Core Set (cancer panel),GSM269271,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 48.1,Revised Gleason Score: 9,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 2.4,Time (yrs) from RRP to first rising PSA: 0.331279945242984,Second Rising PSA (ng/ml): 3.6,Time (yrs) from RRP to second rising PSA: 0.815879534565366,PSA Slope (ng/ml/yr): 2.47627118644068,Time (yrs) from PSA recurrence to systemic disease: 3.99452429842574,Years of Followup after RRP: 11.2169746748802,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-432,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269271/GSM269271_1557311024_R005_C008_Red.xml.gz,502
GSM269272,Patient 433 Core Set (cancer panel),GSM269272,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 53,PSA (ng/ml) at RRP: 13,Revised Gleason Score: 7,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 7.59206023271732,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 8.7501711156742,PSA Slope (ng/ml/yr): 0.863475177304964,Time (yrs) from PSA recurrence to systemic disease: 3.98083504449008,Years of Followup after RRP: 17.5167693360712,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-433,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269272/GSM269272_1557311024_R006_C008_Red.xml.gz,502
GSM269273,Patient 434 Core Set (cancer panel),GSM269273,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 16.9,Revised Gleason Score: 5,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.19028062970568,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 2.31348391512663,PSA Slope (ng/ml/yr): 1.62333333333333,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.0513347022587,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-434,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269273/GSM269273_1557311024_R007_C008_Red.xml.gz,502
GSM269274,Patient 436 Core Set (cancer panel),GSM269274,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 8.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.5523613963039,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-436,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269274/GSM269274_1557311024_R008_C008_Red.xml.gz,502
GSM269275,Patient 437 Core Set (cancer panel),GSM269275,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 10.4,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.37,Time (yrs) from RRP to first rising PSA: 7.11841204654346,Second Rising PSA (ng/ml): 0.52,Time (yrs) from RRP to second rising PSA: 8.42436687200547,PSA Slope (ng/ml/yr): 0.114858490566038,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.4346338124572,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-437,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269275/GSM269275_1557311024_R001_C009_Red.xml.gz,502
GSM269276,Patient 438 Core Set (cancer panel),GSM269276,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 6.2,Revised Gleason Score: 10,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): 1,Time (yrs) from RRP to first rising PSA: 1.70294318959617,Second Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to second rising PSA: 1.82888432580424,PSA Slope (ng/ml/yr): 0.794021739130436,Time (yrs) from PSA recurrence to systemic disease: 2.94045174537988,Years of Followup after RRP: 7.4715947980835,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1438,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269276/GSM269276_1632413020_R008_C004_Red.xml.gz,502
GSM269277,Patient 439 Core Set (cancer panel),GSM269277,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 76,PSA (ng/ml) at RRP: 21,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.45242984257358,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1439,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269277/GSM269277_1632413020_R001_C005_Red.xml.gz,502
GSM269278,Patient 441 Core Set (cancer panel),GSM269278,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 17.2,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.42915811088296,Second Rising PSA (ng/ml): 0.49,Time (yrs) from RRP to second rising PSA: 2.072553045859,PSA Slope (ng/ml/yr): 0.450734042553191,Time (yrs) from PSA recurrence to systemic disease: 3.33196440793977,Years of Followup after RRP: 5.77960301163587,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-441,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269278/GSM269278_1557311024_R005_C009_Red.xml.gz,502
GSM269279,Patient 442 Core Set (cancer panel),GSM269279,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 6.5160848733744,Second Rising PSA (ng/ml): 2.2,Time (yrs) from RRP to second rising PSA: 7.4880219028063,PSA Slope (ng/ml/yr): 1.54330985915493,Time (yrs) from PSA recurrence to systemic disease: 4.05749486652977,Years of Followup after RRP: 16.5119780971937,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-442,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269279/GSM269279_1557311024_R006_C009_Red.xml.gz,502
GSM269280,Patient 443 Core Set (cancer panel),GSM269280,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 8.4,Revised Gleason Score: 7,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.4585900068446,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-443,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269280/GSM269280_1557311024_R007_C009_Red.xml.gz,502
GSM269281,Patient 444 Core Set (cancer panel),GSM269281,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 8.09582477754962,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 9.32238193018481,PSA Slope (ng/ml/yr): 0.244587053571429,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.1156741957563,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-444,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269281/GSM269281_1557311024_R008_C009_Red.xml.gz,502
GSM269282,Patient 445 Core Set (cancer panel),GSM269282,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 40.9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 2.00136892539357,Second Rising PSA (ng/ml): 0.37,Time (yrs) from RRP to second rising PSA: 2.17932922655715,PSA Slope (ng/ml/yr): 0.842884615384615,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-445,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269282/GSM269282_1557311024_R001_C010_Red.xml.gz,502
GSM269283,Patient 446 Core Set (cancer panel),GSM269283,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 11.3,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.33949349760438,Second Rising PSA (ng/ml): 0.43,Time (yrs) from RRP to second rising PSA: 5.01574264202601,PSA Slope (ng/ml/yr): 0.340111336032389,Time (yrs) from PSA recurrence to systemic disease: 3.25256673511294,Years of Followup after RRP: 12.8186173853525,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1446,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269283/GSM269283_1632413020_R002_C005_Red.xml.gz,502
GSM269284,Patient 447 Core Set (cancer panel),GSM269284,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 7.9,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 0.15605749486653,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 0.320328542094456,PSA Slope (ng/ml/yr): 0.60875,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.04585900068446,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-447,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269284/GSM269284_1557311024_R003_C010_Red.xml.gz,502
GSM269285,Patient 448 Core Set (cancer panel),GSM269285,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 17.9,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.2012320328542,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-448,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269285/GSM269285_1557311024_R004_C010_Red.xml.gz,502
GSM269286,Patient 449 Core Set (cancer panel),GSM269286,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 8.6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 1.97946611909651,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 2.27241615331964,PSA Slope (ng/ml/yr): 2.73084112149533,Time (yrs) from PSA recurrence to systemic disease: 0.197125256673511,Years of Followup after RRP: 11.1238877481177,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-449,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269286/GSM269286_1557311024_R005_C010_Red.xml.gz,502
GSM269287,Patient 450 Core Set (cancer panel),GSM269287,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 57,PSA (ng/ml) at RRP: 11.6,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.0479123887748,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-450,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269287/GSM269287_1557311024_R006_C010_Red.xml.gz,502
GSM269288,Patient 451 Core Set (cancer panel),GSM269288,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 21.2,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.5585215605749,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-451,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269288/GSM269288_1557311024_R007_C010_Red.xml.gz,502
GSM269289,Patient 452 Core Set (cancer panel),GSM269289,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 20.6,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.186173853524983,Second Rising PSA (ng/ml): 1,Time (yrs) from RRP to second rising PSA: 0.459958932238193,PSA Slope (ng/ml/yr): 2.55675,Time (yrs) from PSA recurrence to systemic disease: 1.08418891170431,Years of Followup after RRP: 5.70294318959617,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-452,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269289/GSM269289_1557311024_R008_C010_Red.xml.gz,502
GSM269290,Patient 453 Core Set (cancer panel),GSM269290,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 2.29979466119096,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 2.55167693360712,PSA Slope (ng/ml/yr): 0.397010869565217,Time (yrs) from PSA recurrence to systemic disease: 2.45311430527036,Years of Followup after RRP: 12.8733744010951,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-453,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269290/GSM269290_1557311024_R001_C011_Red.xml.gz,502
GSM269291,Patient 454 Core Set (cancer panel),GSM269291,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 17.3,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.33401779603012,Second Rising PSA (ng/ml): 11.84,Time (yrs) from RRP to second rising PSA: 5.87816563997262,PSA Slope (ng/ml/yr): 7.53813829787234,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.0958247775496,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-454,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269291/GSM269291_1557311024_R003_C011_Red.xml.gz,502
GSM269292,Patient 455 Core Set (cancer panel),GSM269292,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 7.1,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.2395619438741,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-455,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269292/GSM269292_1557311024_R004_C011_Red.xml.gz,502
GSM269293,Patient 456 Core Set (cancer panel),GSM269293,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 2,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 3.16221765913758,Second Rising PSA (ng/ml): 0.9,Time (yrs) from RRP to second rising PSA: 3.39219712525667,PSA Slope (ng/ml/yr): 0.869642857142857,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.72347707049966,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-456,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269293/GSM269293_1557311024_R005_C011_Red.xml.gz,502
GSM269294,Patient 457 Core Set (cancer panel),GSM269294,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 3.3,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.85352498288843,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-457,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269294/GSM269294_1557311024_R006_C011_Red.xml.gz,502
GSM269295,Patient 458 Core Set (cancer panel),GSM269295,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.210814510609172,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 0.616016427104723,PSA Slope (ng/ml/yr): 0.740371621621622,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.4674880219028,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-458,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269295/GSM269295_1557311024_R007_C011_Red.xml.gz,502
GSM269296,Patient 459 Core Set (cancer panel),GSM269296,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 5.5,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.63791923340178,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-459,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269296/GSM269296_1557311024_R008_C011_Red.xml.gz,502
GSM269297,Patient 460 Core Set (cancer panel),GSM269297,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 4.1,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.26830937713895,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 5.56878850102669,PSA Slope (ng/ml/yr): 0.0768947368421052,Time (yrs) from PSA recurrence to systemic disease: 4.17248459958932,Years of Followup after RRP: 11.7043121149897,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-460,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269297/GSM269297_1557311024_R002_C012_Red.xml.gz,502
GSM269298,Patient 461 Core Set (cancer panel),GSM269298,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 7.9,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.249144421629021,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 0.347707049965777,PSA Slope (ng/ml/yr): 2.02916666666667,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.30937713894593,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-461,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269298/GSM269298_1557311024_R003_C012_Red.xml.gz,502
GSM269299,Patient 462 Core Set (cancer panel),GSM269299,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 5.8,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 1,Time (yrs) from RRP to first rising PSA: 3.27173169062286,Second Rising PSA (ng/ml): 2.5,Time (yrs) from RRP to second rising PSA: 3.83299110198494,PSA Slope (ng/ml/yr): 2.67256097560976,Time (yrs) from PSA recurrence to systemic disease: 3.08281998631075,Years of Followup after RRP: 10.7378507871321,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-462,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269299/GSM269299_1557311024_R004_C012_Red.xml.gz,502
GSM269300,Patient 463 Core Set (cancer panel),GSM269300,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 12.7,Revised Gleason Score: 5,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.5023956194387,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-463,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269300/GSM269300_1557311024_R005_C012_Red.xml.gz,502
GSM269301,Patient 464 Core Set (cancer panel),GSM269301,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 8.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 6.63107460643395,Second Rising PSA (ng/ml): 2.5,Time (yrs) from RRP to second rising PSA: 7.63586584531143,PSA Slope (ng/ml/yr): 1.99046321525886,Time (yrs) from PSA recurrence to systemic disease: 2.93497604380561,Years of Followup after RRP: 13.0814510609172,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-464,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269301/GSM269301_1557311024_R006_C012_Red.xml.gz,502
GSM269302,Patient 465 Core Set (cancer panel),GSM269302,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 49,PSA (ng/ml) at RRP: 3.1,Revised Gleason Score: 6,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.79,Time (yrs) from RRP to first rising PSA: 2.48049281314168,Second Rising PSA (ng/ml): 3,Time (yrs) from RRP to second rising PSA: 2.98973305954825,PSA Slope (ng/ml/yr): 4.33979838709677,Time (yrs) from PSA recurrence to systemic disease: 0.769336071184121,Years of Followup after RRP: 10.0643394934976,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-465,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269302/GSM269302_1557311024_R007_C012_Red.xml.gz,502
GSM269303,Patient 466 Core Set (cancer panel),GSM269303,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 13.9,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.58,Time (yrs) from RRP to first rising PSA: 2.04517453798768,Second Rising PSA (ng/ml): 0.66,Time (yrs) from RRP to second rising PSA: 2.05886379192334,PSA Slope (ng/ml/yr): 5.84400000000001,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.54140999315537,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1466,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269303/GSM269303_1632413020_R003_C005_Red.xml.gz,502
GSM269304,Patient 467 Core Set (cancer panel),GSM269304,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 12.5,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.55,Time (yrs) from RRP to first rising PSA: 8.18891170431212,Second Rising PSA (ng/ml): 1,Time (yrs) from RRP to second rising PSA: 9.76043805612594,PSA Slope (ng/ml/yr): 0.286345818815331,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.025325119781,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-467,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269304/GSM269304_1557302053_R007_C001_Red.xml.gz,502
GSM269305,Patient 468 Core Set (cancer panel),GSM269305,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 6.7,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.88774811772758,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1468,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269305/GSM269305_1632413020_R004_C005_Red.xml.gz,502
GSM269306,Patient 469 Core Set (cancer panel),GSM269306,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 76,PSA (ng/ml) at RRP: 75,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to first rising PSA: 0.714579055441478,Second Rising PSA (ng/ml): 2.2,Time (yrs) from RRP to second rising PSA: 0.991101984941821,PSA Slope (ng/ml/yr): 3.9779702970297,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.1800136892539,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-469,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269306/GSM269306_1557302053_R001_C002_Red.xml.gz,502
GSM269307,Patient 470 Core Set (cancer panel),GSM269307,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 7.1,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 6.39014373716632,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1470,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269307/GSM269307_1632413020_R005_C005_Red.xml.gz,502
GSM269308,Patient 471 Core Set (cancer panel),GSM269308,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 15.1,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 0.265571526351814,Second Rising PSA (ng/ml): 1,Time (yrs) from RRP to second rising PSA: 0.780287474332649,PSA Slope (ng/ml/yr): 1.1656914893617,Time (yrs) from PSA recurrence to systemic disease: 2.20396988364134,Years of Followup after RRP: 17.5578370978782,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-471,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269308/GSM269308_1557302053_R003_C002_Red.xml.gz,502
GSM269309,Patient 472 Core Set (cancer panel),GSM269309,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 7.8,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.766598220396988,Second Rising PSA (ng/ml): 0.38,Time (yrs) from RRP to second rising PSA: 1.24572210814511,PSA Slope (ng/ml/yr): 0.375685714285714,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 5.33607118412047,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-472,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269309/GSM269309_1557302053_R004_C002_Red.xml.gz,502
GSM269310,Patient 473 Core Set (cancer panel),GSM269310,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.284736481861739,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 0.919917864476386,PSA Slope (ng/ml/yr): 0.314870689655172,Time (yrs) from PSA recurrence to systemic disease: 2.8227241615332,Years of Followup after RRP: 9.04585900068446,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-473,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269310/GSM269310_1557302053_R005_C002_Red.xml.gz,502
GSM269311,Patient 474 Core Set (cancer panel),GSM269311,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 4.8,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.2888432580424,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1474,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269311/GSM269311_1632413020_R006_C005_Red.xml.gz,502
GSM269312,Patient 475 Core Set (cancer panel),GSM269312,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 8.6,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 18.8,Time (yrs) from RRP to first rising PSA: 2.82546201232033,Second Rising PSA (ng/ml): 20.1,Time (yrs) from RRP to second rising PSA: 2.91581108829569,PSA Slope (ng/ml/yr): 14.3886363636364,Time (yrs) from PSA recurrence to systemic disease: 2.98699520876112,Years of Followup after RRP: 6.74058863791923,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-475,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269312/GSM269312_1557302053_R007_C002_Red.xml.gz,502
GSM269313,Patient 476 Core Set (cancer panel),GSM269313,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 6,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.68240930869268,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-476,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269313/GSM269313_1557302053_R002_C003_Red.xml.gz,502
GSM269314,Patient 477 Core Set (cancer panel),GSM269314,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 6,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.2970568104038,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-477,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269314/GSM269314_1557302053_R003_C003_Red.xml.gz,502
GSM269315,Patient 478 Core Set (cancer panel),GSM269315,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 13.8,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.11430527036277,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 1.73305954825462,PSA Slope (ng/ml/yr): 0.161615044247788,Time (yrs) from PSA recurrence to systemic disease: 3.27173169062286,Years of Followup after RRP: 12.9418206707734,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-478,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269315/GSM269315_1557302053_R004_C003_Red.xml.gz,502
GSM269316,Patient 479 Core Set (cancer panel),GSM269316,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 27,Revised Gleason Score: 7,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 3.02532511978097,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 4.36960985626283,PSA Slope (ng/ml/yr): 0.22316700610998,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.3203285420945,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-479,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269316/GSM269316_1557302053_R005_C003_Red.xml.gz,502
GSM269317,Patient 480 Core Set (cancer panel),GSM269317,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 22.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.514715947980835,Second Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to second rising PSA: 1.88637919233402,PSA Slope (ng/ml/yr): 0.218712574850299,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 6.95687885010267,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-480,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269317/GSM269317_1557302053_R006_C003_Red.xml.gz,502
GSM269318,Patient 481 Core Set (cancer panel),GSM269318,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 21.4,Revised Gleason Score: 8,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.9,Time (yrs) from RRP to first rising PSA: 3.36481861738535,Second Rising PSA (ng/ml): 2.3,Time (yrs) from RRP to second rising PSA: 3.38945927446954,PSA Slope (ng/ml/yr): 16.2333333333333,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.10609171800137,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-481,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269318/GSM269318_1557302053_R007_C003_Red.xml.gz,502
GSM269319,Patient 482 Core Set (cancer panel),GSM269319,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 31.7,Revised Gleason Score: 8,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.62,Time (yrs) from RRP to first rising PSA: 2.99794661190965,Second Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to second rising PSA: 3.4798083504449,PSA Slope (ng/ml/yr): 0.996136363636364,Time (yrs) from PSA recurrence to systemic disease: 4.89253935660506,Years of Followup after RRP: 10.7707049965777,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-482,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269319/GSM269319_1557302053_R008_C003_Red.xml.gz,502
GSM269320,Patient 483 Core Set (cancer panel),GSM269320,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 15.3,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.22,Time (yrs) from RRP to first rising PSA: 0.517453798767967,Second Rising PSA (ng/ml): 1.3,Time (yrs) from RRP to second rising PSA: 1.45106091718001,PSA Slope (ng/ml/yr): 1.15680351906158,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.709787816564,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-483,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269320/GSM269320_1557302053_R001_C004_Red.xml.gz,502
GSM269321,Patient 484 Core Set (cancer panel),GSM269321,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 22,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.9924709103354,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-484,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269321/GSM269321_1557302053_R002_C004_Red.xml.gz,502
GSM269322,Patient 485 Core Set (cancer panel),GSM269322,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 25.8,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.52,Time (yrs) from RRP to first rising PSA: 1.7056810403833,Second Rising PSA (ng/ml): 1.6,Time (yrs) from RRP to second rising PSA: 2.13004791238877,PSA Slope (ng/ml/yr): 2.54496774193548,Time (yrs) from PSA recurrence to systemic disease: 1.88637919233402,Years of Followup after RRP: 5.09787816563997,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-485,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269322/GSM269322_1557302053_R003_C004_Red.xml.gz,502
GSM269323,Patient 486 Core Set (cancer panel),GSM269323,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 9.7,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 6.72689938398357,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-486,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269323/GSM269323_1557302053_R004_C004_Red.xml.gz,502
GSM269324,Patient 488 Core Set (cancer panel),GSM269324,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 4.7,Revised Gleason Score: 9,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.38,Time (yrs) from RRP to first rising PSA: 0.514715947980835,Second Rising PSA (ng/ml): 0.61,Time (yrs) from RRP to second rising PSA: 0.750171115674196,PSA Slope (ng/ml/yr): 0.976831395348837,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.1895961670089,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-488,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269324/GSM269324_1557302053_R005_C004_Red.xml.gz,502
GSM269325,Patient 489 Core Set (cancer panel),GSM269325,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 24.8,Revised Gleason Score: 7,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.9459274469541,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-489,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269325/GSM269325_1557302053_R006_C004_Red.xml.gz,502
GSM269326,Patient 490 Core Set (cancer panel),GSM269326,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 56,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 59,Time (yrs) from RRP to first rising PSA: 0.298425735797399,Second Rising PSA (ng/ml): 70,Time (yrs) from RRP to second rising PSA: 0.407939767282683,PSA Slope (ng/ml/yr): 100.44375,Time (yrs) from PSA recurrence to systemic disease: 0.774811772758385,Years of Followup after RRP: 8.76386036960986,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-490,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269326/GSM269326_1557302053_R007_C004_Red.xml.gz,502
GSM269327,Patient 491 Core Set (cancer panel),GSM269327,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 42.6,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.5,Time (yrs) from RRP to first rising PSA: 0.375085557837098,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 0.528405201916496,PSA Slope (ng/ml/yr): 0.652232142857143,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.2347707049966,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-491,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269327/GSM269327_1557302053_R008_C004_Red.xml.gz,502
GSM269328,Patient 492 Core Set (cancer panel),GSM269328,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 14,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.11635865845311,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 3.01163586584531,PSA Slope (ng/ml/yr): 0.111697247706422,Time (yrs) from PSA recurrence to systemic disease: 2.95414099931554,Years of Followup after RRP: 9.08966461327858,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-492,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269328/GSM269328_1557302053_R001_C005_Red.xml.gz,502
GSM269329,Patient 493 Core Set (cancer panel),GSM269329,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 47.4,Revised Gleason Score: 7,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.1964407939767,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-493,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269329/GSM269329_1557302053_R002_C005_Red.xml.gz,502
GSM269330,Patient 494 Core Set (cancer panel),GSM269330,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 40.1,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 1,Time (yrs) from RRP to first rising PSA: 0.878850102669405,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 1.07323750855578,PSA Slope (ng/ml/yr): 1.02887323943662,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.77275838466804,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-494,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269330/GSM269330_1557302053_R003_C005_Red.xml.gz,502
GSM269331,Patient 495 Core Set (cancer panel),GSM269331,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 63,PSA (ng/ml) at RRP: 28.3,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.31895961670089,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 4.26557152635181,PSA Slope (ng/ml/yr): 0.0513713080168776,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.9883641341547,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-495,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269331/GSM269331_1557302053_R004_C005_Red.xml.gz,502
GSM269332,Patient 496 Core Set (cancer panel),GSM269332,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 55,PSA (ng/ml) at RRP: 3.5,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.1820670773443,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-496,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269332/GSM269332_1557302053_R005_C005_Red.xml.gz,502
GSM269333,Patient 497 Core Set (cancer panel),GSM269333,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 51,PSA (ng/ml) at RRP: 9.5,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 4.49555099247091,Second Rising PSA (ng/ml): 0.34,Time (yrs) from RRP to second rising PSA: 5.65092402464066,PSA Slope (ng/ml/yr): 0.121172985781991,Time (yrs) from PSA recurrence to systemic disease: 2.88021902806297,Years of Followup after RRP: 9.65913757700205,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-497,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269333/GSM269333_1557302053_R006_C005_Red.xml.gz,502
GSM269334,Patient 498 Core Set (cancer panel),GSM269334,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 57,PSA (ng/ml) at RRP: 6.5,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 2.22313483915127,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 2.41752224503765,PSA Slope (ng/ml/yr): 0.51443661971831,Time (yrs) from PSA recurrence to systemic disease: 1.05407255304586,Years of Followup after RRP: 7.6249144421629,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-498,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269334/GSM269334_1557302053_R007_C005_Red.xml.gz,502
GSM269335,Patient 499 Core Set (cancer panel),GSM269335,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 31.7,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 5.45379876796715,Second Rising PSA (ng/ml): 5.3,Time (yrs) from RRP to second rising PSA: 8.85420944558522,PSA Slope (ng/ml/yr): 1.49981884057971,Time (yrs) from PSA recurrence to systemic disease: 2.0643394934976,Years of Followup after RRP: 14.0999315537303,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-499,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269335/GSM269335_1557302053_R008_C005_Red.xml.gz,502
GSM269336,Patient 500 Core Set (cancer panel),GSM269336,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 16.5,Revised Gleason Score: 10,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 7,Time (yrs) from RRP to first rising PSA: 0.476386036960986,Second Rising PSA (ng/ml): 11.4,Time (yrs) from RRP to second rising PSA: 1.03764544832307,PSA Slope (ng/ml/yr): 7.83951219512195,Time (yrs) from PSA recurrence to systemic disease: 1.22929500342231,Years of Followup after RRP: 4.93908281998631,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-500,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269336/GSM269336_1557302053_R001_C006_Red.xml.gz,502
GSM269337,Patient 501 Core Set (cancer panel),GSM269337,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 12.2,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.3340177960301,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-501,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269337/GSM269337_1557302053_R002_C006_Red.xml.gz,502
GSM269338,Patient 503 Core Set (cancer panel),GSM269338,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 15.9,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.31211498973306,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 0.709103353867214,PSA Slope (ng/ml/yr): 0.251896551724138,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 5.86721423682409,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-503,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269338/GSM269338_1557302053_R004_C006_Red.xml.gz,502
GSM269339,Patient 504 Core Set (cancer panel),GSM269339,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 53,PSA (ng/ml) at RRP: 5.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.37440109514031,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-504,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269339/GSM269339_1557302053_R005_C006_Red.xml.gz,502
GSM269340,Patient 505 Core Set (cancer panel),GSM269340,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 83.5,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.8001368925394,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-505,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269340/GSM269340_1557302053_R006_C006_Red.xml.gz,502
GSM269341,Patient 506 Core Set (cancer panel),GSM269341,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 15.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.0417522245038,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-506,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269341/GSM269341_1557302053_R007_C006_Red.xml.gz,502
GSM269342,Patient 507 Core Set (cancer panel),GSM269342,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 5.7,Revised Gleason Score: 9,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 3,Time (yrs) from RRP to first rising PSA: 2.08624229979466,Second Rising PSA (ng/ml): 7.2,Time (yrs) from RRP to second rising PSA: 2.42026009582478,PSA Slope (ng/ml/yr): 12.5741803278689,Time (yrs) from PSA recurrence to systemic disease: 2.57357973990418,Years of Followup after RRP: 6.6009582477755,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-507,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269342/GSM269342_1557302053_R008_C006_Red.xml.gz,502
GSM269343,Patient 508 Core Set (cancer panel),GSM269343,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 58,PSA (ng/ml) at RRP: 2.3,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to first rising PSA: 2.45037645448323,Second Rising PSA (ng/ml): 0.8,Time (yrs) from RRP to second rising PSA: 2.46954140999316,PSA Slope (ng/ml/yr): 10.4357142857143,Time (yrs) from PSA recurrence to systemic disease: 1.54962354551677,Years of Followup after RRP: 7.54551676933607,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-508,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269343/GSM269343_1557302053_R001_C007_Red.xml.gz,502
GSM269344,Patient 509 Core Set (cancer panel),GSM269344,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 62,PSA (ng/ml) at RRP: 25,Revised Gleason Score: 8,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to first rising PSA: 5.31690622861054,Second Rising PSA (ng/ml): 2,Time (yrs) from RRP to second rising PSA: 5.72758384668036,PSA Slope (ng/ml/yr): 2.1915,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.5290896646133,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-509,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269344/GSM269344_1557302053_R002_C007_Red.xml.gz,502
GSM269345,Patient 510 Core Set (cancer panel),GSM269345,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 4.9,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 2.58726899383984,Second Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to second rising PSA: 2.92950034223135,PSA Slope (ng/ml/yr): 0.8766,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 8.50924024640657,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-510,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269345/GSM269345_1557302053_R003_C007_Red.xml.gz,502
GSM269346,Patient 511 Core Set (cancer panel),GSM269346,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 5.2,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.7857631759069,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-511,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269346/GSM269346_1557302053_R004_C007_Red.xml.gz,502
GSM269347,Patient 512 Core Set (cancer panel),GSM269347,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 6.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 9.98220396988364,Second Rising PSA (ng/ml): 0.45,Time (yrs) from RRP to second rising PSA: 10.9733059548255,PSA Slope (ng/ml/yr): 0.151346685082873,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.5503080082136,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-512,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269347/GSM269347_1557302053_R005_C007_Red.xml.gz,502
GSM269348,Patient 513 Core Set (cancer panel),GSM269348,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 5,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.0527036276523,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-513,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269348/GSM269348_1557302053_R006_C007_Red.xml.gz,502
GSM269349,Patient 514 Core Set (cancer panel),GSM269349,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 3.8,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.37782340862423,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 10.715947980835,PSA Slope (ng/ml/yr): 0.096729343220339,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 16.3613963039014,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-514,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269349/GSM269349_1557302053_R007_C007_Red.xml.gz,502
GSM269350,Patient 515 Core Set (cancer panel),GSM269350,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 57,PSA (ng/ml) at RRP: 31,Revised Gleason Score: 9,Stage: TxN+,Ploidy: tetraploid,First Rising PSA (ng/ml): 1.9,Time (yrs) from RRP to first rising PSA: 3.03080082135524,Second Rising PSA (ng/ml): 2.1,Time (yrs) from RRP to second rising PSA: 3.30184804928131,PSA Slope (ng/ml/yr): 0.737878787878788,Time (yrs) from PSA recurrence to systemic disease: 3.58658453114305,Years of Followup after RRP: 7.85215605749487,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-515,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269350/GSM269350_1557302053_R008_C007_Red.xml.gz,502
GSM269351,Patient 516 Core Set (cancer panel),GSM269351,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 73,PSA (ng/ml) at RRP: 7.1,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 0.31211498973306,Second Rising PSA (ng/ml): 1.4,Time (yrs) from RRP to second rising PSA: 0.435318275154004,PSA Slope (ng/ml/yr): 5.68166666666667,Time (yrs) from PSA recurrence to systemic disease: 2.95140314852841,Years of Followup after RRP: 4.99931553730322,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-516,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269351/GSM269351_1557302053_R001_C008_Red.xml.gz,502
GSM269352,Patient 517 Core Set (cancer panel),GSM269352,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 70,PSA (ng/ml) at RRP: 3.6,Revised Gleason Score: 8,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 3.93976728268309,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 6.02327173169062,PSA Slope (ng/ml/yr): 0.0959921156373193,Time (yrs) from PSA recurrence to systemic disease: 1.83436002737851,Years of Followup after RRP: 16.0985626283368,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-517,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269352/GSM269352_1557302053_R002_C008_Red.xml.gz,502
GSM269353,Patient 518 Core Set (cancer panel),GSM269353,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 69,PSA (ng/ml) at RRP: 47.2,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.0150581793292,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-518,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269353/GSM269353_1557302053_R003_C008_Red.xml.gz,502
GSM269354,Patient 519 Core Set (cancer panel),GSM269354,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 46.6,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.23,Time (yrs) from RRP to first rising PSA: 1.98767967145791,Second Rising PSA (ng/ml): 0.35,Time (yrs) from RRP to second rising PSA: 2.40383299110198,PSA Slope (ng/ml/yr): 0.288355263157895,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.67419575633128,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-519,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269354/GSM269354_1557302053_R004_C008_Red.xml.gz,502
GSM269355,Patient 520 Core Set (cancer panel),GSM269355,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 64,PSA (ng/ml) at RRP: 7.5,Revised Gleason Score: 7,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.4168377823409,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-520,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269355/GSM269355_1557302053_R005_C008_Red.xml.gz,502
GSM269356,Patient 521 Core Set (cancer panel),GSM269356,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 87,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 13.8,Time (yrs) from RRP to first rising PSA: 2.27789185489391,Second Rising PSA (ng/ml): 20.5,Time (yrs) from RRP to second rising PSA: 2.32717316906229,PSA Slope (ng/ml/yr): 135.954166666667,Time (yrs) from PSA recurrence to systemic disease: 3.15126625598905,Years of Followup after RRP: 7.31827515400411,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-521,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269356/GSM269356_1557302053_R006_C008_Red.xml.gz,502
GSM269357,Patient 522 Core Set (cancer panel),GSM269357,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 52,PSA (ng/ml) at RRP: 33.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.27,Time (yrs) from RRP to first rising PSA: 1.06228610540726,Second Rising PSA (ng/ml): 0.34,Time (yrs) from RRP to second rising PSA: 1.4757015742642,PSA Slope (ng/ml/yr): 0.16932119205298,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.44969199178645,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-522,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269357/GSM269357_1557302053_R007_C008_Red.xml.gz,502
GSM269358,Patient 523 Core Set (cancer panel),GSM269358,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 76,PSA (ng/ml) at RRP: 8.9,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.23,Time (yrs) from RRP to first rising PSA: 8.94182067077344,Second Rising PSA (ng/ml): 1.8,Time (yrs) from RRP to second rising PSA: 9.9356605065024,PSA Slope (ng/ml/yr): 1.57973140495868,Time (yrs) from PSA recurrence to systemic disease: 0.960985626283368,Years of Followup after RRP: 14.3107460643395,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1523,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269358/GSM269358_1632413020_R004_C002_Red.xml.gz,502
GSM269359,Patient 524 Core Set (cancer panel),GSM269359,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 201,Revised Gleason Score: 8,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.276522929500342,Second Rising PSA (ng/ml): 0.9,Time (yrs) from RRP to second rising PSA: 0.544832306639288,PSA Slope (ng/ml/yr): 2.60892857142857,Time (yrs) from PSA recurrence to systemic disease: 5.87268993839836,Years of Followup after RRP: 12.8843258042437,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-524,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269359/GSM269359_1557302053_R001_C009_Red.xml.gz,502
GSM269360,Patient 525 Core Set (cancer panel),GSM269360,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 53,PSA (ng/ml) at RRP: 2.3,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.555099247091,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-525,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269360/GSM269360_1557302053_R002_C009_Red.xml.gz,502
GSM269361,Patient 526 Core Set (cancer panel),GSM269361,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 5.4,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 5.47843942505133,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 6.23682409308693,PSA Slope (ng/ml/yr): 0.131859205776173,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 13.1225188227242,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-1526,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269361/GSM269361_1632413020_R002_C002_Red.xml.gz,502
GSM269362,Patient 527 Core Set (cancer panel),GSM269362,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 22.3,Revised Gleason Score: 7,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 11.9,Time (yrs) from RRP to first rising PSA: 9.36618754277892,Second Rising PSA (ng/ml): 14.2,Time (yrs) from RRP to second rising PSA: 9.46748802190281,PSA Slope (ng/ml/yr): 22.7047297297297,Time (yrs) from PSA recurrence to systemic disease: 0.416153319644079,Years of Followup after RRP: 11.6030116358658,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-527,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269362/GSM269362_1557302053_R004_C009_Red.xml.gz,502
GSM269363,Patient 528 Core Set (cancer panel),GSM269363,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 74,PSA (ng/ml) at RRP: 12.2,Revised Gleason Score: 7,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 10.90212183436,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-528,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269363/GSM269363_1557302053_R005_C009_Red.xml.gz,502
GSM269364,Patient 529 Core Set (cancer panel),GSM269364,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 21.4,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 1.66735112936345,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 2.17659137577002,PSA Slope (ng/ml/yr): 0.392741935483871,Time (yrs) from PSA recurrence to systemic disease: 1.75496235455168,Years of Followup after RRP: 12.394250513347,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-529,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269364/GSM269364_1557302053_R006_C009_Red.xml.gz,502
GSM269365,Patient 530 Core Set (cancer panel),GSM269365,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 58,PSA (ng/ml) at RRP: 10.7,Revised Gleason Score: 8,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.818617385352498,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 1.02395619438741,PSA Slope (ng/ml/yr): 0.487,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.70431211498973,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-530,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269365/GSM269365_1557302053_R007_C009_Red.xml.gz,502
GSM269366,Patient 531 Core Set (cancer panel),GSM269366,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: val,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 9,Revised Gleason Score: 9,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.5975359342916,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-531,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269366/GSM269366_1557302053_R008_C009_Red.xml.gz,502
GSM269367,Patient 533 Core Set (cancer panel),GSM269367,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 60,PSA (ng/ml) at RRP: 8,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): 0.36,Time (yrs) from RRP to first rising PSA: 2.11088295687885,Second Rising PSA (ng/ml): 1.2,Time (yrs) from RRP to second rising PSA: 2.71321013004791,PSA Slope (ng/ml/yr): 1.39459090909091,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.870636550308,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-533,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269367/GSM269367_1557302053_R002_C010_Red.xml.gz,502
GSM269368,Patient 534 Core Set (cancer panel),GSM269368,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 4.3,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.7,Time (yrs) from RRP to first rising PSA: 2.62833675564682,Second Rising PSA (ng/ml): 2.2,Time (yrs) from RRP to second rising PSA: 3.78097193702943,PSA Slope (ng/ml/yr): 1.30136579572447,Time (yrs) from PSA recurrence to systemic disease: 0.281998631074606,Years of Followup after RRP: 7.59479808350445,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-534,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269368/GSM269368_1557302053_R003_C010_Red.xml.gz,502
GSM269369,Patient 536 Core Set (cancer panel),GSM269369,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 130,Revised Gleason Score: 8,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 4.1,Time (yrs) from RRP to first rising PSA: 0.643394934976044,Second Rising PSA (ng/ml): 24,Time (yrs) from RRP to second rising PSA: 2.94592744695414,PSA Slope (ng/ml/yr): 8.64265755053508,Time (yrs) from PSA recurrence to systemic disease: 0.232717316906229,Years of Followup after RRP: 5.72758384668036,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-536,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269369/GSM269369_1557302053_R004_C010_Red.xml.gz,502
GSM269370,Patient 537 Core Set (cancer panel),GSM269370,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 67,PSA (ng/ml) at RRP: 9.9,Revised Gleason Score: 10,Stage: TxN+,Ploidy: diploid,First Rising PSA (ng/ml): 0.59,Time (yrs) from RRP to first rising PSA: 1.44832306639288,Second Rising PSA (ng/ml): 1.75,Time (yrs) from RRP to second rising PSA: 1.73032169746749,PSA Slope (ng/ml/yr): 4.11349514563107,Time (yrs) from PSA recurrence to systemic disease: 1.86995208761123,Years of Followup after RRP: 4.47364818617385,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-537,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269370/GSM269370_1557302053_R005_C010_Red.xml.gz,502
GSM269371,Patient 538 Core Set (cancer panel),GSM269371,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 71,PSA (ng/ml) at RRP: 3.5,Revised Gleason Score: 9,Stage: T3aN0,Ploidy: tetraploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 14.6995208761123,patient's status: Deceased,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-538,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269371/GSM269371_1557302053_R006_C010_Red.xml.gz,502
GSM269372,Patient 539 Core Set (cancer panel),GSM269372,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 56,PSA (ng/ml) at RRP: 21.4,Revised Gleason Score: 7,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 3.12388774811773,Second Rising PSA (ng/ml): 0.6,Time (yrs) from RRP to second rising PSA: 3.64134154688569,PSA Slope (ng/ml/yr): 0.579761904761905,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.4250513347023,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-539,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269372/GSM269372_1557302053_R007_C010_Red.xml.gz,502
GSM269373,Patient 540 Core Set (cancer panel),GSM269373,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 14.6,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.2,Time (yrs) from RRP to first rising PSA: 0.563997262149213,Second Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to second rising PSA: 0.835044490075291,PSA Slope (ng/ml/yr): 0.368939393939394,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 7.84394250513347,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-540,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269373/GSM269373_1557302053_R008_C010_Red.xml.gz,502
GSM269374,Patient 541 Core Set (cancer panel),GSM269374,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 89.2,Revised Gleason Score: 8,Stage: TxN+,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 4.50650239561944,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 5.02943189596167,PSA Slope (ng/ml/yr): 0.191230366492147,Time (yrs) from PSA recurrence to systemic disease: 3.20876112251882,Years of Followup after RRP: 10.3846680355921,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-541,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269374/GSM269374_1557302053_R002_C011_Red.xml.gz,502
GSM269375,Patient 542 Core Set (cancer panel),GSM269375,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: val,Age (yrs) at RRP: 59,PSA (ng/ml) at RRP: NA,Revised Gleason Score: 7,Stage: T2N0,Ploidy: NA,First Rising PSA (ng/ml): 0.27,Time (yrs) from RRP to first rising PSA: 10.5845311430527,Second Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to second rising PSA: 11.772758384668,PSA Slope (ng/ml/yr): 0.10940668202765,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 15.9014373716632,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-542,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269375/GSM269375_1557302053_R003_C011_Red.xml.gz,502
GSM269376,Patient 543 Core Set (cancer panel),GSM269376,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 68,PSA (ng/ml) at RRP: 39.2,Revised Gleason Score: 7,Stage: T2N0,Ploidy: aneuploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 12.9418206707734,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-543,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269376/GSM269376_1557302053_R004_C011_Red.xml.gz,502
GSM269377,Patient 544 Core Set (cancer panel),GSM269377,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: PSA,Training or Validation: trn,Age (yrs) at RRP: 65,PSA (ng/ml) at RRP: 9.3,Revised Gleason Score: 8,Stage: T3aN0,Ploidy: diploid,First Rising PSA (ng/ml): 0.4,Time (yrs) from RRP to first rising PSA: 2.46954140999316,Second Rising PSA (ng/ml): 1.1,Time (yrs) from RRP to second rising PSA: 3.0280629705681,PSA Slope (ng/ml/yr): 1.25330882352941,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 11.0910335386721,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-544,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269377/GSM269377_1557302053_R005_C011_Red.xml.gz,502
GSM269378,Patient 545 Core Set (cancer panel),GSM269378,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: NED,Training or Validation: trn,Age (yrs) at RRP: 66,PSA (ng/ml) at RRP: 6.1,Revised Gleason Score: 6,Stage: T2N0,Ploidy: diploid,First Rising PSA (ng/ml): NA,Time (yrs) from RRP to first rising PSA: NA,Second Rising PSA (ng/ml): NA,Time (yrs) from RRP to second rising PSA: NA,PSA Slope (ng/ml/yr): NA,Time (yrs) from PSA recurrence to systemic disease: NA,Years of Followup after RRP: 9.3388090349076,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-545,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269378/GSM269378_1557302053_R006_C011_Red.xml.gz,502
GSM269379,Patient 546 Core Set (cancer panel),GSM269379,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: trn,Age (yrs) at RRP: 58,PSA (ng/ml) at RRP: 11.4,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: aneuploid,First Rising PSA (ng/ml): 0.21,Time (yrs) from RRP to first rising PSA: 2.90759753593429,Second Rising PSA (ng/ml): 0.77,Time (yrs) from RRP to second rising PSA: 3.46611909650924,PSA Slope (ng/ml/yr): 1.00264705882353,Time (yrs) from PSA recurrence to systemic disease: 0.476386036960986,Years of Followup after RRP: 5.61806981519507,patient's status: Alive,Prostate cancer specific death: No,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-546,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269379/GSM269379_1557302053_R007_C011_Red.xml.gz,502
GSM269380,Patient 547 Core Set (cancer panel),GSM269380,Public on Jun 10 2008,Feb 26 2008,Jun 10 2008,RNA,1,primary prostate cancer,Homo sapiens,Case-Control Group: Systemic,Training or Validation: val,Age (yrs) at RRP: 72,PSA (ng/ml) at RRP: 8,Revised Gleason Score: 9,Stage: T3bN0,Ploidy: tetraploid,First Rising PSA (ng/ml): 0.3,Time (yrs) from RRP to first rising PSA: 0.848733744010951,Second Rising PSA (ng/ml): 0.39,Time (yrs) from RRP to second rising PSA: 1.11156741957563,PSA Slope (ng/ml/yr): 0.342421875,Time (yrs) from PSA recurrence to systemic disease: 0.257357973990418,Years of Followup after RRP: 2.50513347022587,patient's status: Deceased,Prostate cancer specific death: Yes,total RNA,"Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions",9606,hybridization was performed in accordance with the manufacturer's instructions,Arrays were scanned using Illumina's BeadArray Reader,TNPr-547,Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.,GPL5858,"Robert,B.,Jenkins",rjenkins@mayo.edu,Laboratory Medicine and Pathology,Mayo Clinic,200 First Street SW,Rochester,MN,55905,USA,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Grn.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Grn.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Grn.xml.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Red.idat.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Red.jpg.gz,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM269nnn/GSM269380/GSM269380_1557302053_R008_C011_Red.xml.gz,502
